Jenburkt Pharmaceuticals's quarterly market cap
declined
from Sep. 2023 (₹3,091 Mil) to Dec. 2023 (₹3,002 Mil) but then
increased
from Dec. 2023 (₹3,002 Mil) to Mar. 2024 (₹3,043 Mil).
Jenburkt Pharmaceuticals's annual market cap
increased
from Mar. 2022 (₹2,601 Mil) to Mar. 2023 (₹2,939 Mil) and
increased
from Mar. 2023 (₹2,939 Mil) to Mar. 2024 (₹3,043 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Jenburkt Pharmaceuticals's Enterprise Value for Today is ₹3,015 Mil.
Jenburkt Pharmaceuticals Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Jenburkt Pharmaceuticals's Market Cap
For the Drug Manufacturers - Specialty & Generic subindustry, Jenburkt Pharmaceuticals's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenburkt Pharmaceuticals's Market Cap Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jenburkt Pharmaceuticals's Market Cap distribution charts can be found below:
* The bar in red indicates where Jenburkt Pharmaceuticals's Market Cap falls into.
Jenburkt Pharmaceuticals Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Jenburkt Pharmaceuticals's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenburkt Pharmaceuticals (BOM:524731) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Jenburkt Pharmaceuticals Market Cap Related Terms
Thank you for viewing the detailed overview of Jenburkt Pharmaceuticals's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Jenburkt Pharmaceuticals (BOM:524731) Business Description
Jenburkt Pharmaceuticals Ltd is engaged in the manufacturing, producing, developing, and marketing of pharmaceutical formulations. The company operates in one segment - pharmaceutical formulations. The company generates key revenue from the local market.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524731 has been successfully added to your 